Dyne Therapeutics Inc. shares surged more than 40% after people with knowledge of the matter said the developer of drugs to treat muscle diseases has received takeover interest from larger pharmaceutical companies. The Waltham, Massachusetts-based company has been speaking with advisers as it considers options including a possible sale or partnership, according to the people, who asked not to be identified discussing confidential information.